ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Hiromasa Morikawa
Hiromasa Morikawa, M.D., PhD
Background
2017.9 - present AstraZeneca (Japan), Science Lead at Medical Affaiers (Immuno-Oncology)
2004.4 - 2008.3 Department of Thoracic Surgery, National Hospital Organization Nagara Medical Center, Gifu, Medical Doctor
2002.4 - 2004.3 Department of Thoracic Surgery, Fukui Redcross Hospital, Fukui, Medical Doctor
2001.4 - 2002.3 Department of Thoracic Surgery, Kyoto University Hospital, Kyoto, Medical Doctor
Other Interests
Mediatinal tumor
Chest wall tumor
Carcinoma of the lung
Immunology
Research
2017.4 - present King Abdullah University of Science and Technology, Research Consultant
2014.9 - 2017.9 Unit of Computational Medicine, Department of Medicine, Karolinska Institutet, Postdoctoral Fellow
2014.4 - 2014.8 Experimental immunology, Immunology Frontier Research Center, Osaka University, Assistant Professor
2012.4 - 2014.3 Experimental immunology, Immunology Frontier Research Center, Osaka University, Specially appointed researcher
Additional Educational Information
2008.4 – 2012.3 Kyoto University Graduate School of Medicine, Kyoto (2013.11.25 PhD) (Institute for Frontier Medical Sciences, Kyoto University & Laboratory of Experimental Immunology WPI Immunology Frontier Research Center (IFReC), Osaka University)
1995.4 - 2001.3 Kyoto University Medical School (2001.3 M.D.)
1993.4 - 1995.3 Faculty of Science, Kyoto University
Printer-friendly